Skip to content
Intent.Health — AI That’s Natively Healthcare
INTENT.HEALTH / INSIGHTSAll resources ↗
FDA Clearances & Devices

FDA Clears First Over-the-Counter Glucose Monitor for Children

By Intent.Health Team • June 12, 2026
fda clears first

What's happening

The FDA cleared the first over-the-counter continuous glucose monitor that can be purchased for children without a prescription. The device allows families to monitor glucose levels more easily and may improve access to diabetes-management technology.

What's changing / Business impact

The approval reflects a broader trend toward making health-monitoring technologies more accessible directly to consumers. Removing prescription requirements can simplify access and potentially increase adoption.

Why this matters

Continuous glucose monitors have transformed diabetes care by allowing patients and caregivers to track blood sugar levels in real time. For families with children who have diabetes, easier access to monitoring technology can improve disease management and reduce some of the burden associated with daily care.

Core takeaway

The FDA is making advanced diabetes-monitoring technology easier for families to access.

YOUR NEXT MOVE

Bring your market into focus.

See how organizations, people, clinical activity and intent come together for your team.

Explore your use case ↗